GO:0045943 positive regulation of transcription by RNA polymerase I: Ribosome Biogenesis Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045943 describes any process that activates or increases the frequency, rate or extent of transcription mediated by RNA polymerase I, the enzyme dedicated to ribosomal RNA synthesis.
• The term covers both direct stimulation of the Pol I pre-initiation complex and indirect activation through signaling pathways, chromatin remodelers and metabolic sensors.
• Key positive regulators include SIRT7, STAT3, EGR1, DDX21, the SWI/SNF complex and the RRN3 adaptor, all of which converge on rDNA promoter activity.
• Dysregulated Pol I activation is a hallmark of cancer, where elevated rRNA synthesis supports unrestricted ribosome production and tumor growth.
• Loss of Pol I transcription factors such as HEATR1 triggers the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint, linking GO:0045943 to p53-dependent growth arrest.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of positive Pol I regulators in human cells.
Description
Positive regulation of transcription by RNA polymerase I (GO:0045943) is the biological process that activates or increases the frequency, rate or extent of transcription mediated by RNA polymerase I. RNA polymerase I (Pol I) is the dedicated enzyme for ribosomal RNA (rRNA) synthesis, producing the 47S precursor that is processed into 18S, 5.8S and 28S rRNA, the structural and catalytic core of the ribosome. Because ribosome biogenesis is tightly coupled to cell growth and proliferation, the positive regulation of Pol I transcription is a central node in growth control and a frequent target of oncogenic signaling. Researchers study GO:0045943 to understand how cells match protein synthesis capacity to nutrient availability, how oncogenes hijack rRNA synthesis, and how ribosome biogenesis stress is sensed by the p53 pathway. The process is executed by a defined set of transcription factors, chromatin remodelers and signaling kinases that converge on the rDNA promoter, making it experimentally tractable with modern CRISPR and genomics tools.
positive regulation of transcription by RNA polymerase I At A Glance
| GO ID | GO:0045943 |
|---|---|
| GO term | positive regulation of transcription by RNA polymerase I |
| Ontology | biological_process |
| Synonym | activation of transcription from RNA polymerase I promoter; positive regulation of transcription from Pol I promoter; stimulation of transcription from RNA polymerase I promoter; up regulation of transcription from RNA polymerase I promoter |
| Major function | Increases the frequency, rate or extent of RNA polymerase I-mediated transcription, primarily of ribosomal RNA genes |
| Cellular context | Nucleolus and rDNA chromatin, where Pol I and its associated factors assemble |
| Key regulators | SIRT7, STAT3, EGR1, DDX21, SWI/SNF complex, RRN3 |
| Disease relevance | Cancer growth, ribosome biogenesis stress, p53-dependent checkpoint activation |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, RNA-seq, Ribo-seq, ChIP, imaging |
What Is GO:0045943?
GO:0045943 is defined by QuickGO as any process that activates or increases the frequency, rate or extent of transcription mediated by RNA polymerase I. In practice, this includes mechanisms that stimulate assembly or activity of the Pol I pre-initiation complex at the rDNA promoter, enhance elongation of the 47S rRNA transcript, or relieve repression of rDNA chromatin, all of which increase the output of rRNA synthesis.
Why Is positive regulation of transcription by RNA polymerase I Important in Cell Biology?
Positive regulation of transcription by RNA polymerase I is important because it sets the upper limit for ribosome production and therefore for protein synthesis capacity, cell growth and proliferation. Cells must rapidly and reversibly adjust rRNA synthesis in response to nutrients, growth factors and stress, and failure to do so contributes to cancer, developmental disorders and ribosomopathies. Because Pol I transcription is a point of convergence for oncogenic and tumor-suppressive signals, it is both a mechanistic window into growth control and a candidate therapeutic axis.
• Controls the rate-limiting step of ribosome biogenesis and global protein synthesis capacity.
• Integrates growth factor and oncogenic signaling with rRNA output, supporting tumor growth.
• Couples rRNA synthesis to rRNA processing through factors such as DDX21.
• Links Pol I activity to the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint.
• Provides a mechanistic explanation for how chromatin remodelers influence rDNA transcription.
• Is modulated by sirtuin-dependent deacetylation and kinase signaling.
• Offers druggable targets for cancers addicted to high rRNA synthesis.
• Serves as a model for studying nucleolar structure and function.
• Helps explain how cells adapt translation to metabolic state.
• Enables CRISPR-based causal testing of candidate regulators in human cells.
What Happens During positive regulation of transcription by RNA polymerase I?
Activation of the Pol I pre-initiation complex
In simple terms: The cell assembles a molecular machine on the rDNA promoter to start making ribosomal RNA.
Positive regulation begins with recruitment and activation of the Pol I pre-initiation complex at the rDNA promoter. The RRN3 adaptor is a key target: EGR1 promotes Pol I-directed transcription and cancer growth by activating RRN3 expression, thereby increasing the available active Pol I pool. STAT3 similarly potentiates Pol I-directed transcription by activating RPA34 expression, a subunit of the Pol I machinery. These examples show that positive regulation can act by increasing the abundance or activity of core Pol I components.
Chromatin remodeling at rDNA
In simple terms: The DNA packaging around ribosomal RNA genes must be opened so the transcription machinery can access it.
The SWI/SNF chromatin remodeling complex influences transcription by RNA polymerase I in Saccharomyces cerevisiae, demonstrating that ATP-dependent nucleosome remodeling is part of positive regulation. By altering nucleosome positioning at rDNA, SWI/SNF facilitates access of Pol I and its associated factors, thereby increasing transcription. This chromatin-level control is an essential layer of GO:0045943.
Coordination with rRNA processing
In simple terms: Making rRNA and processing it into mature pieces are physically and functionally linked.
The RNA helicase DDX21 coordinates transcription and ribosomal RNA processing, coupling the output of Pol I transcription with downstream rRNA maturation. This coordination ensures that increased transcription is matched by processing capacity, and it illustrates that positive regulation of Pol I transcription is integrated with the broader ribosome biogenesis program.
Sirtuin and kinase-dependent activation
In simple terms: Enzymes that add or remove chemical marks on proteins can switch Pol I transcription up.
Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription, providing a direct example of enzymatic positive regulation. SIRT7-dependent deacetylation of CDK9 activates RNA polymerase II transcription, showing that sirtuin-dependent deacetylation is a general mechanism for activating transcription. DNA-dependent protein kinase can inhibit Pol I transcription, indicating that kinase signaling can also negatively tune the process and that positive regulators must overcome such brakes.
Checkpoint coupling to p53
In simple terms: When the ribosomal RNA transcription machinery is perturbed, the cell can trigger a stress alarm that stops growth.
Perturbation of the RNA polymerase I transcription machinery by ablation of HEATR1 triggers the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint pathway in human cells. This means that positive regulation of Pol I transcription is monitored, and its disruption can activate p53-dependent responses. Understanding this coupling is essential for interpreting phenotypes of Pol I regulator perturbations.
Key Genes Involved in GO:0045943 positive regulation of transcription by RNA polymerase I
The following genes and proteins have been experimentally implicated in the positive regulation of RNA polymerase I transcription, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DDX21 | RNA helicase coordinating Pol I transcription and rRNA processing | Links transcription output to rRNA maturation; candidate for ribosome biogenesis studies |
| STAT3 | Potentiates Pol I-directed transcription by activating RPA34 expression | Oncogenic regulator of rRNA synthesis and tumor growth |
| HEATR1 | Component of Pol I transcription machinery; its ablation triggers ribosome biogenesis stress | Model for p53-dependent checkpoint activation |
| DNA-PK | DNA-dependent protein kinase that inhibits Pol I transcription | Negative regulator providing a brake on rRNA synthesis |
| CDK9 | Deacetylation target of SIRT7; activates RNA polymerase II transcription | Illustrates sirtuin-dependent activation mechanisms relevant to transcription control |
| SIRT7 | Activator of RNA polymerase I transcription | Enzymatic positive regulator; target for modulating rRNA synthesis |
| EGR1 | Promotes Pol I-directed transcription and cancer growth by activating RRN3 expression | Transcription factor linking growth signals to Pol I activation |
| RRN3 | Adaptor required for active Pol I initiation; induced by EGR1 | Core positive regulator of Pol I transcription |
| RPA34 | Pol I subunit induced by STAT3 | Effector of STAT3-driven Pol I activation |
| SWI/SNF complex | Chromatin remodeler influencing Pol I transcription | Chromatin-level positive regulator of rDNA transcription |
| RPL5 | Ribosomal protein mediating ribosome biogenesis stress checkpoint | Connects Pol I perturbation to p53 activation |
| RPL11 | Ribosomal protein mediating ribosome biogenesis stress checkpoint | Connects Pol I perturbation to p53 activation |
| MDM2 | E3 ubiquitin ligase regulated by RPL5/RPL11 during stress | Effector of p53 checkpoint downstream of Pol I perturbation |
| p53 | Tumor suppressor activated by ribosome biogenesis stress | Readout of Pol I transcription perturbation |
| Pol I (RNA polymerase I) | Core enzyme transcribing rRNA genes | Central target of positive regulation |
| CDK9 (Pol II context) | SIRT7 substrate; activation of Pol II transcription | Comparative example of sirtuin-dependent transcription activation |
How Is positive regulation of transcription by RNA polymerase I Regulated?
Positive regulation of transcription by RNA polymerase I is itself regulated at multiple levels. SIRT7 acts as an enzymatic activator of Pol I transcription, and sirtuin-dependent deacetylation of CDK9 activates RNA polymerase II transcription, indicating that acetylation state is a control layer. DNA-dependent protein kinase can inhibit Pol I transcription, showing that kinase signaling provides a negative brake that positive regulators must overcome. Growth factor and oncogenic pathways converge on Pol I: STAT3 potentiates Pol I-directed transcription by activating RPA34 expression, and EGR1 promotes Pol I-directed transcription by activating RRN3 expression. Chromatin remodeling by SWI/SNF influences Pol I transcription, adding a nucleosome-level regulatory mechanism. Finally, perturbation of the Pol I machinery by HEATR1 ablation activates the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint, coupling Pol I activity to cell fate decisions.
positive regulation of transcription by RNA polymerase I and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| STAT3 | Cancer; promotes Pol I transcription and tumor growth | Knockout or point-mutation in cancer cell lines; xenograft models |
| EGR1 | Cancer; activates RRN3 to drive Pol I transcription | Overexpression and knockout models in tumor cells |
| HEATR1 | Ribosome biogenesis stress; activates p53 checkpoint | Knockout in human cells to induce RPL5/RPL11-MDM2-p53 pathway |
| DDX21 | Nucleolar function; couples transcription and rRNA processing | Knockout or tagged knock-in for localization and interaction studies |
| SIRT7 | Transcription regulation; activator of Pol I transcription | Knockout and point-mutation models to test enzymatic activity |
Cancer
Positive regulation of Pol I transcription supports the high ribosome biogenesis rates required by cancer cells. STAT3 potentiates Pol I-directed transcription and tumor growth by activating RPA34 expression, directly linking GO:0045943 to oncogenesis. EGR1 promotes Pol I-directed transcription and cancer growth by activating RRN3 expression, providing a second oncogenic route to Pol I activation. These findings suggest that tumors may depend on sustained positive regulation of Pol I transcription, making this process a candidate therapeutic target.
Ribosome biogenesis stress and p53 activation
Perturbation of the RNA polymerase I transcription machinery by ablation of HEATR1 triggers the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint pathway in human cells. This links defects in positive regulation of Pol I transcription to p53-dependent growth arrest, a mechanism relevant to ribosomopathies and to the cellular response to Pol I inhibitors.
Nucleolar function and RNA processing disorders
DDX21 coordinates transcription and ribosomal RNA processing, so disruption of this coordination could impair ribosome assembly and nucleolar function. Because DDX21 couples Pol I transcription with rRNA processing, its dysfunction may contribute to diseases characterized by defective ribosome biogenesis.
From positive regulation of transcription by RNA polymerase I-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for Pol I transcription? | CRISPR knockout in human cell lines followed by rRNA quantification |
| Does a specific residue mediate activation? | Point-mutation knock-in of the candidate gene |
| Where does the factor localize in the nucleolus? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression increase rRNA synthesis? | Overexpression cell model with rRNA readout |
| Does the factor interact with Pol I machinery? | Knock-in with affinity tag and co-immunoprecipitation |
| Does perturbation activate p53 checkpoint? | Knockout model with p53 and RPL5/RPL11 readouts |
How to Study the positive regulation of transcription by RNA polymerase I Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcript levels including rRNA precursors | Assessing Pol I transcription output after perturbation |
| Ribo-seq | Ribosome occupancy and translation efficiency | Linking Pol I activation to protein synthesis |
| ChIP | Association of factors with rDNA chromatin | Testing SWI/SNF or Pol I factor recruitment |
| Co-immunoprecipitation | Protein-protein interactions | Validating interactions with Pol I machinery |
| Fluorescence imaging | Nucleolar localization and structure | Visualizing tagged factors and nucleolar activity |
| qRT-PCR | Specific rRNA and mRNA levels | Quantifying Pol I transcription changes |
| Western blot | Protein expression and modification | Detecting RPA34, RRN3, p53 and checkpoint proteins |
| CRISPR screening | Phenotypes of many gene knockouts | Identifying novel positive regulators of Pol I transcription |
RNA-seq and rRNA quantification
RNA-seq and targeted rRNA quantification measure the output of Pol I transcription after genetic perturbation. In HEATR1 knockout cells, perturbation of the Pol I machinery activates the RPL5/RPL11-MDM2-p53 checkpoint, which can be monitored by transcriptomic readouts. Overexpression of STAT3 or EGR1 increases Pol I-directed transcription, which can be quantified by rRNA levels.
Ribo-seq and translation profiling
Ribo-seq measures ribosome occupancy and global translation, providing a functional readout of changes in rRNA synthesis driven by positive regulation of Pol I transcription. Because DDX21 coordinates transcription and rRNA processing, combining Ribo-seq with rRNA processing assays gives a fuller picture.
Chromatin and interaction assays
ChIP and co-immunoprecipitation can test whether candidate regulators associate with rDNA or with Pol I subunits. The SWI/SNF complex influences Pol I transcription, and its recruitment to rDNA can be assessed by chromatin-based methods. Tagged knock-in of factors such as DDX21 enables interaction studies.
Imaging of nucleolar activity
Fluorescence imaging of nucleolar markers and tagged Pol I factors visualizes changes in nucleolar structure and activity. DDX21 localization and its coordination with rRNA processing can be imaged in live or fixed cells. SIRT7-dependent activation of Pol I transcription can be monitored by nucleolar readouts.
How CRISPR Can Be Used to Study GO:0045943 positive regulation of transcription by RNA polymerase I
Knockout
CRISPR knockout is used to test whether a candidate gene is required for positive regulation of Pol I transcription. Ablation of HEATR1 perturbs the Pol I transcription machinery and triggers the RPL5/RPL11-MDM2-p53 checkpoint, demonstrating the power of knockout to reveal checkpoint coupling. Knockout of STAT3 or EGR1 would test their requirement for Pol I activation and tumor growth.
Point Mutation
Point-mutation models test whether specific residues or enzymatic activities are required for positive regulation. SIRT7 is an activator of Pol I transcription, and point mutations in its catalytic domain can dissect whether deacetylation activity is needed. Similarly, mutations in CDK9 acetylation sites can test SIRT7-dependent activation mechanisms.
Knock-in
Knock-in of tags or reporters enables localization and interaction studies. Tagged knock-in of DDX21 allows tracking of its coordination with rRNA processing. Knock-in of fluorescent reporters at rDNA or Pol I subunits can provide real-time readouts of transcription activation.
Overexpression
Overexpression models test sufficiency of a candidate regulator. Overexpression of STAT3 potentiates Pol I-directed transcription and tumor growth by activating RPA34 expression. Overexpression of EGR1 promotes Pol I-directed transcription and cancer growth by activating RRN3 expression. These models are useful for identifying downstream effectors and therapeutic vulnerabilities.
How EDITGENE Supports positive regulation of transcription by RNA polymerase I Research
Researchers studying positive regulation of transcription by RNA polymerase I-related genes often need to determine whether a candidate gene is causally involved in rRNA synthesis, ribosome biogenesis and disease phenotypes. EDITGENE provides publication-ready CRISPR cell models and screening services to test these hypotheses rigorously.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of transcription by RNA polymerase I research.
Frequently Asked Questions About positive regulation of transcription by RNA polymerase I
What is GO:0045943?
GO:0045943 is the Gene Ontology term for positive regulation of transcription by RNA polymerase I, defined as any process that activates or increases the frequency, rate or extent of transcription mediated by RNA polymerase I.
What genes are involved in positive regulation of transcription by RNA polymerase I?
Key genes include DDX21, STAT3, HEATR1, SIRT7, EGR1, RRN3, RPA34 and components of the SWI/SNF complex, all supported by experimental literature.
How does STAT3 regulate RNA polymerase I transcription?
STAT3 potentiates Pol I-directed transcription and tumor growth by activating RPA34 expression.
How does EGR1 regulate RNA polymerase I transcription?
EGR1 promotes Pol I-directed transcription and cancer growth by activating RRN3 expression.
What happens when the Pol I transcription machinery is perturbed?
Perturbation by ablation of HEATR1 triggers the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint pathway in human cells.
Is SIRT7 a positive regulator of Pol I transcription?
Yes, mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription.
Does chromatin remodeling affect Pol I transcription?
Yes, the SWI/SNF chromatin remodeling complex influences transcription by RNA polymerase I in Saccharomyces cerevisiae.
How is Pol I transcription inhibited?
DNA-dependent protein kinase can inhibit RNA polymerase I transcription, providing a negative regulatory mechanism.
What methods are used to study positive regulation of Pol I transcription?
Common methods include RNA-seq, Ribo-seq, ChIP, co-immunoprecipitation, imaging, qRT-PCR, Western blot and CRISPR screening.
Why is positive regulation of Pol I transcription important in cancer?
It supports the high ribosome biogenesis rates needed for tumor growth, as shown for STAT3 and EGR1-driven Pol I activation.
Conclusion
GO:0045943, positive regulation of transcription by RNA polymerase I, is a central biological process that controls rRNA synthesis and ribosome biogenesis. Experimental evidence implicates DDX21, STAT3, HEATR1, SIRT7, EGR1, RRN3, RPA34 and the SWI/SNF complex in activating Pol I transcription, with direct links to cancer growth and p53-dependent stress checkpoints. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with RNA-seq, Ribo-seq and chromatin assays, provide a rigorous path to dissect these mechanisms. EDITGENE supports researchers with tailored cell models and screening services to accelerate discovery in this field.
References
- 1. Calo E et al.. 2015. RNA helicase DDX21 coordinates transcription and ribosomal RNA processing.. Nature 518(7538):249-53 PMID: 25470060
- 2. Zhang C et al.. 2023. STAT3 potentiates RNA polymerase I-directed transcription and tumor growth by activating RPA34 expression.. Br J Cancer 128(5):766-782 PMID: 36526675
- 3. Turi Z et al.. 2018. Perturbation of RNA Polymerase I transcription machinery by ablation of HEATR1 triggers the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint pathway in human cells.. Cell Cycle 17(1):92-101 PMID: 29143558
- 4. Michaelidis TM et al.. 2002. Mechanism of inhibition of RNA polymerase I transcription by DNA-dependent protein kinase.. Biol Chem 383(11):1683-90 PMID: 12530533
- 5. Blank MF et al.. 2017. SIRT7-dependent deacetylation of CDK9 activates RNA polymerase II transcription.. Nucleic Acids Res 45(5):2675-2686 PMID: 28426094
- 6. Ford E et al.. 2006. Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription.. Genes Dev 20(9):1075-80 PMID: 16618798
- 7. Song X et al.. 2026. Early growth response 1 promotes RNA polymerase I-directed transcription and cancer growth by activating RRN3 expression.. Commun Biol 9(1):209 PMID: 41507426
- 8. Zhang Y et al.. 2013. The SWI/SNF chromatin remodeling complex influences transcription by RNA polymerase I in Saccharomyces cerevisiae.. PLoS One 8(2):e56793 PMID: 23437238
